Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingavirin for Post-exposure Prophylaxis of Influenza/ARVI
NCT03189537Phase 3Completed
- Sponsor
- Valenta Pharm
- Start
- Oct 2010
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Ingavirin in influenza, acute respiratory viral infection (ARVI), sponsored by Valenta Pharm. Started Oct 2010; status: completed.
02
Drugs
Ingavirin
03
Conditions
influenzaacute respiratory viral infection (ARVI)
Beyond the preview
Go deeper on NCT03189537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03189537.